The chief executive officer of Cytoimmune discussed the company’s technology platforms and programs.
Christine Coughlin, MD, PhD
Advertisement
Articles by Christine Coughlin, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – November 26, 2025
2
FDA Approves Itvisma, a New Intrathecal Route for Novartis’ SMA Gene Therapy
3
Guess the Therapy Answer November 26, 2025
4
Sarepta's Elevidys Gets Boxed Warning for ALI and ALF
5
